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Elsevier B.V. This iswww.sciencedirect.comEditorialInterest in functional materials, nanocarriers, and formulations for
targeted therapy, which can selectively deliver therapeutic or
diagnostic payloads to target sites such as organs, tissues, cells,
and subcellular organelles, is continuously growing because such a
targeted strategy may facilitate greater accumulation of the
delivered payloads at sites of interest and less accumulation at
non-target sites, which can then result in maximized therapeutic
efﬁcacy and minimized undesirable effects. In addition, controlling
drug releasing rates from nanocarriers and formulations could be
included in targeted therapy: fast release, sustained/prolonged
release, timed release, controlled release, and site-speciﬁc release.
For delivering and/or releasing drugs at target sites, targeted
systems mostly have used various speciﬁcities such as anatomy,
physiology, pathology, molecular interactions (e.g., antigen-
antibody and receptor-ligand interactions) and internal and exter-
nal triggers (e.g., pH, glutathione, ROS, light, etc.). Such novel
targeting pharmaceutical formulations were prepared based on the
new multi-functional materials, which not only can be used to
increase the solubility of poorly soluble drugs, but also prepare
versatile multi-functional dosage forms for targeting delivery. The
development of functional materials provides the opportunity for
the preparation of targeted drug delivery formulation.16/j.apsb.2016.06.006
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an open access article under the CC BY-NC-ND licenseUnfortunately, this special issue could not introduce all aspects
of broadness in targeted delivery, release, and therapy. Never-
theless, general organ/cell targeting strategies such as brain and
lung are reviewed by Huile Gao and Chuanbin Wu/Xin Pan,
respectively, and speciﬁc brain and lung targeting systems are
introduced by Yongzhuo Huang/Victor C. Yang and Hulin Jiang,
respectively. Using various stimuli in charge-reversal systems is
reviewed by Chen Jiang. Light and pH-triggered carriers are
introduced by Min Suk Shim and Jiwen Zhang/Dawei Chen,
respectively. Strategies for effective cellular internalization are
reported by Venkatareddy Nadithe and Chong Li. Especially, an
example for the sustained release is reported by Rui Ding/Yao Fu.
Scientists from the United States, Republic of Korea and China
contributed elaborated reviews and valuable research works on
functional material synthesis and novel nanocarriers for targeting
drug and gene delivery. We hope this issue provides our readers a
general and speciﬁc background on targeted delivery, release, and
therapy.Medica, Chinese Academy of Medical Sciences. Production and hosting by
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
